Tus kws kho mob
QP81-18 Changes to Cotiviti Mailroom Operations Center Location
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 25, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2271 - 2280 ntawm 4303
Tus kws kho mob
QP78-18 Pharmacy Update - Change in Coverage for Brand Serevent Diskus 50 mcg/dose
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 11, 2018
Tus kws kho mob
QP71-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP90-18 Addition of Drugs to the Self-Administered Oncology Agents Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP69-18 Universal Pharmacy Policy for Minnesota Health Care Programs Subscribers - Morphine Equivalent Dose (MED) Limit Update
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP75-18 2018 Blue Cross Blue Shield MHCP Migration and New Initiatives Training
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 07, 2018
Tus kws kho mob
QP93-18 Technical Issues with Authorization and Referral Tool on Availity Resolved
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP79-18 Addition of Drug to the Hereditary Angioedema Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP77-18 Pharmacy Benefit Exclusion for Onpattro (patisiran) Lipid Complex Intravenous (IV) Injection
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 11, 2018
Tus kws kho mob
QP57-18 New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary Angioedema
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 19, 2018